Serum bilirubin: a prognostic factor in primary biliary cirrhosis
- PMID: 428825
- PMCID: PMC1419455
- DOI: 10.1136/gut.20.2.137
Serum bilirubin: a prognostic factor in primary biliary cirrhosis
Abstract
We followed up 55 patients with proven primary biliary cirrhosis for several years or until death. A graph of the level of serum bilirubin versus time that was constructed for each patient shows an initial period of variable length in which the serum bilirubin level remained constant. This was followed by a period of rapid rise in serum bilirubin which culminated in the patient's death. Whenever two successive serum bilirubin values taken six months apart exceeded 34 mumol/l (2.0 mg/dl) the patient had entered a late phase of disease and lived an average of 49 months. Ninety-five per cent confidence limits on survival time were 32-74 months. If two successive six month bilirubin values exceeded 102 mumol/l (6.0 mg/dl), calculated survival time was 25 months, and if two successive six month bilirubin values exceeded 170 mumol/l (10.0 mg/dl), survival time was 17 months. Fifteen of the 41 living patients had two consecutive serum bilirubin levels greater than 34 mumol/l (2.0 mg/dl). However, the slope of the rising bilirubin in the living patients is only 35 mumol/l/yr (1.5 mg/dl/yr) compared with 42 mumol/l/yr (2.5 mg/dl/yr) in the dead patients. This means that patients with this disease not may be living considerably longer.
Similar articles
-
Referral of patients with primary biliary cirrhosis for liver transplantation.Gut. 1990 Sep;31(9):1069-72. doi: 10.1136/gut.31.9.1069. Gut. 1990. PMID: 2210454 Free PMC article.
-
Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.Am J Gastroenterol. 2006 Sep;101(9):2044-50. doi: 10.1111/j.1572-0241.2006.00699.x. Epub 2006 Jul 18. Am J Gastroenterol. 2006. PMID: 16848809
-
Percutaneous biliary drainage effectively lowers serum bilirubin to permit chemotherapy treatment.Abdom Radiol (NY). 2016 Feb;41(2):317-23. doi: 10.1007/s00261-015-0580-z. Abdom Radiol (NY). 2016. PMID: 26867914
-
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S9-17. Liver Transpl Surg. 1998. PMID: 9742489 Review.
-
The use of ursodeoxycholic acid in patients with primary biliary cirrhosis: sense or nonsense.Acta Gastroenterol Belg. 2003 Oct-Dec;66(4):283-7. Acta Gastroenterol Belg. 2003. PMID: 14989050 Review.
Cited by
-
Primary biliary cirrhosis: From bench to bedside.World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):32-58. doi: 10.4292/wjgpt.v6.i3.32. World J Gastrointest Pharmacol Ther. 2015. PMID: 26261733 Free PMC article. Review.
-
Opioid peptides and primary biliary cirrhosis.BMJ. 1988 Dec 10;297(6662):1501-4. doi: 10.1136/bmj.297.6662.1501. BMJ. 1988. PMID: 3147046 Free PMC article. Clinical Trial.
-
Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.Curr Gastroenterol Rep. 1999 Apr;1(2):95-101. doi: 10.1007/s11894-996-0006-8. Curr Gastroenterol Rep. 1999. PMID: 10980934 Review.
-
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis.Gut. 2002 Aug;51(2):265-9. doi: 10.1136/gut.51.2.265. Gut. 2002. PMID: 12117892 Free PMC article.
-
Cirrhosis and autoimmune liver disease: Current understanding.World J Hepatol. 2016 Oct 8;8(28):1157-1168. doi: 10.4254/wjh.v8.i28.1157. World J Hepatol. 2016. PMID: 27729952 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources